Breaks Categories: News

TuesdayNov 30, 2021 10:30 am

CannabisNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Announces Q3 2021 Results, Including 93% YOY Revenue Increase

Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF), a multistate cannabis operator and house of premium brands, today announced 2021 third quarter financial results. Among the highlights, the company reported a 93% increase in third quarter year-over-year revenue. “In the third quarter, we made excellent progress in laying additional building blocks in our core operating states of Florida, Michigan and California to become more vertically integrated where it will be most profitable,” said Brad Rogers, RWB chairman and CEO. “This will help drive increased revenue and margins for the company. Simultaneously, we are gaining significant market share with our…

Continue Reading

MondayNov 29, 2021 12:17 pm

CannabisNewsBreaks – RYAH Group Inc. (CSE: RYAH) Announces Refiling of Amended, Restated MD&A and Financial Statements

RYAH Group (CSE: RYAH), a connected device and big data and technology company focused on valuable predictive analysis in the global medical plant and nutraceutical intake industry, has amended, restated and refiled information covering the three and six months ended June 30, 2021. Information refiled includes RYAH’s management discussion and analysis (“MD&A”) and condensed, consolidated interim financial statements for the six months ended June 30, 2021. The MD&A material includes information regarding the company's operations, business objectives, and relationships with third parties as well as marketing expenditures incurred during the three- and six-month period ended June 30, 2021. The material…

Continue Reading

MondayNov 29, 2021 10:40 am

CannabisNewsBreaks – BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) Releases Report on 2021 Shareholder General and Special Meeting

BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC), an emerging leader in innovative health and wellness beverages and products, announced that at its annual general and special meeting of shareholders (“AGM”) all agenda items were approved. The meeting was held on Nov. 24, 2021. Included in the agenda items were the election of directors and the appointment of an auditor. According to the company, four individuals were elected to the board, including Marcello Leone, John Campbell, Martino Ciambrelli and Phil Fontaine. In addition, Dale Matheson Carr-Hilton Labonte LLP (“DMCL”) was reappointed as the company auditor for the next year. To view…

Continue Reading

TuesdayNov 23, 2021 12:36 pm

CannabisNewsBreaks – BevCanna Enterprises Inc.’s (CSE: BEV) (OTCQB: BVNNF) (FSE:7BC) TRACE Selected as Official Water of Country Music Week 2021

BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC), an emerging leader in innovative health and wellness beverages and products, today announced that TRACE will be the exclusive water partner for Country Music Week 2021. Hosted by the Canadian Country Music Association(R) (“CCMA”) in London, Ontario, from Nov. 26-29, 2021, the event will celebrate country music in Canada and culminate with the 2021 CCMA Awards Show to be broadcast in a live special on Nov. 29, 2021. TRACE will keep fans, artists and the Canadian country music industry hydrated in its capacity as the exclusive water partner of Country Music Week…

Continue Reading

FridayNov 19, 2021 10:11 am

CannabisNewsBreaks – Grapefruit USA Inc. (GPFT) Provides Clarification of Execs Sale of Stock

Grapefruit USA (OTCQB: GPFT), a premiere California-based cannabis and hemp company, has released a clarifying statement regarding the sale of stock conducted recently by company executives. According to the announcement, GPFT executives do not take a salary, instead being compensated with GPFT common stock. The company noted that its leaders preferred equity compensation, voting to receive their compensation that way several years ago because it represents the “ultimate incentive to ensure that their interests are fully aligned with the interests of company shareholders — the success of Grapefruit.” In addition, opting for this form of compensation is management strategy that…

Continue Reading

ThursdayNov 18, 2021 2:13 pm

CannabisNewsBreaks – AmeriCann (ACAN) Announces 300% Annual Revenue Increase from Flagship Project

AmeriCann (OTCQB: ACAN), a cannabis company that develops state-of-the-art cultivation, product manufacturing and distribution facilities, today announced financial and operational updates for its flagship project, the Massachusetts Cannabis Center. Located on a 52-acre parcel in southeastern Massachusetts, the project is permitted for 987,000 sq. ft. of cannabis cultivation and processing infrastructure, which is being developed in phases to support multiple tenants in medical and adult-use cannabis markets. “AmeriCann’s operating revenue for the year ending September 2021 increased by over 300% from the prior year,” said CFO Ben Barton. “The strong top-line growth reflects four consecutive quarters of accelerating revenue. We…

Continue Reading

WednesdayNov 17, 2021 2:36 pm

CannabisNewsBreaks – Global Technologies Ltd (GTLL) Announces LOI to Acquire Tersus Power

Global Technologies (OTC: GTLL), a holding corporation with operations engaged in the online sales of CBD and hemp-related products, the acquisition of intellectual property in the safety and security space, and as a portal for entrepreneurs to provide immediate access to live shopping, e-commerce, distribution and logistics, today announced its entry into a letter of intent to acquire Tersus Power. Tersus is focused on designing a safe, adaptable and affordable hydrogen fueling station that allows for rapid development and deployment of hydrogen fueling infrastructure while minimizing the risk to investors. “This is an exciting time for the Global Technologies shareholders,”…

Continue Reading

WednesdayNov 17, 2021 1:57 pm

CannabisNewsBreaks – Way2Grow Biopharma Corp. Enters ‘Next Phase of Life Science Therapeutics’

Way2Grow (“W2G”), a privately held therapeutic corporation existing under the laws of British Columbia, today announced approval of a Health Canada Dealer’s Licence Application. Under the approval, Health Canada issued notice to W2G to complete the construction of a level 8 secure environ and psilocybin production campus. The license and production facility will allow W2G to procure psychedelics as well as propagate, cultivate, harvest and sell psychedelics to pharmacies, clinics and other licenced research facilities for allowable research purposes pursuant to the Controlled Drugs and Substances Act (the “CDSA”). “We are excited to enter this next phase of life science…

Continue Reading

MondayNov 15, 2021 11:30 am

CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Closes Acquisition of Vessel Brand Inc.

Flora Growth (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, has completed the acquisition of Vessel Brand Inc., an industry leader in cannabis consumer technology. According to Flora Growth, the acquisition provides the company with an immediate foothold in the North American cannabis market because Vessel brings with it a trailing 12-months revenue of $6.6 million and year-over-year growth of 90%. In addition, the acquisition diversifies Flora’s premium brand portfolio through Vessel’s strong position in the luxury cannabis consumer technology market. According to the announcement, key Vessel team members will join Flora’s executive bench and…

Continue Reading

WednesdayNov 10, 2021 11:17 am

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Expands 2022 R&D Programs to Evaluate Potential Treatment Options for Alzheimer’s and Diabetes

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced its plans for several new and ongoing DehydraTECH(TM)-applied R&D programs for 2022. According to the update, the studies mentioned in the announcement represent only a fraction of Lexaria's 2022 work programs. “Calendar 2022 will continue to see significant milestones in utilizing DehydraTECH-CBD for investigation of heart disease and hypertension; and separately, for oral nicotine delivery as an alternative to smoking,” said Chris Bunka, CEO of Lexaria Bioscience Corp. “We are delighted to announce that DehydraTECH as an enhanced drug delivery platform will also be evaluated for…

Continue Reading